Credit Suisse’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-18,869
| Closed | -$86K | – | 3555 |
|
2019
Q1 | $86K | Buy |
18,869
+3,626
| +24% | +$16.5K | ﹤0.01% | 3271 |
|
2018
Q4 | $53K | Buy |
15,243
+2,625
| +21% | +$9.13K | ﹤0.01% | 3258 |
|
2018
Q3 | $127K | Sell |
12,618
-7,150
| -36% | -$72K | ﹤0.01% | 3228 |
|
2018
Q2 | $143K | Sell |
19,768
-692
| -3% | -$5.01K | ﹤0.01% | 3340 |
|
2018
Q1 | $124K | Sell |
20,460
-61,468
| -75% | -$373K | ﹤0.01% | 3346 |
|
2017
Q4 | $790K | Buy |
81,928
+48,717
| +147% | +$470K | ﹤0.01% | 2688 |
|
2017
Q3 | $295K | Buy |
33,211
+12,087
| +57% | +$107K | ﹤0.01% | 3271 |
|
2017
Q2 | $267K | Sell |
21,124
-9,879
| -32% | -$125K | ﹤0.01% | 3139 |
|
2017
Q1 | $326K | Buy |
31,003
+2,362
| +8% | +$24.8K | ﹤0.01% | 3125 |
|
2016
Q4 | $264K | Sell |
28,641
-12,983
| -31% | -$120K | ﹤0.01% | 3354 |
|
2016
Q3 | $491K | Sell |
41,624
-15,184
| -27% | -$179K | ﹤0.01% | 3107 |
|
2016
Q2 | $735K | Sell |
56,808
-25,339
| -31% | -$328K | ﹤0.01% | 2886 |
|
2016
Q1 | $1.31M | Buy |
82,147
+33,331
| +68% | +$533K | ﹤0.01% | 2265 |
|
2015
Q4 | $1.4M | Buy |
48,816
+4,696
| +11% | +$134K | ﹤0.01% | 2355 |
|
2015
Q3 | $1.26M | Sell |
44,120
-80,119
| -64% | -$2.28M | ﹤0.01% | 2448 |
|
2015
Q2 | $4.46M | Buy |
124,239
+59,371
| +92% | +$2.13M | ﹤0.01% | 1678 |
|
2015
Q1 | $1.89M | Sell |
64,868
-40,952
| -39% | -$1.19M | ﹤0.01% | 2207 |
|
2014
Q4 | $2.23M | Sell |
105,820
-46,524
| -31% | -$980K | ﹤0.01% | 2154 |
|
2014
Q3 | $2.95M | Buy |
152,344
+120,822
| +383% | +$2.34M | ﹤0.01% | 1884 |
|
2014
Q2 | $493K | Sell |
31,522
-28,714
| -48% | -$449K | ﹤0.01% | 3415 |
|
2014
Q1 | $1.25M | Buy |
60,236
+2,396
| +4% | +$49.6K | ﹤0.01% | 2597 |
|
2013
Q4 | $747K | Buy |
57,840
+9,165
| +19% | +$118K | ﹤0.01% | 3093 |
|
2013
Q3 | $568K | Buy |
+48,675
| New | +$568K | ﹤0.01% | 3009 |
|